Urticaria and angioedema associated with SARS-CoV-2 infection.

Zipursky, Jonathan S; Croitoru, David

Zipursky, Jonathan S; Croitoru, David.

Zipursky JS; Department of Medicine (Zipursky, Croitoru), University of Toronto; Department of Medicine (Zipursky), Sunnybrook Health Sciences Centre; Division of Clinical Pharmacology and Toxicology (Zipursky) and Institute of Health Policy, Management and Evaluation (Zipursky) and Division of Dermatology (Croitoru), University of Toronto, Toronto, Ont. jonathan.zipursky@mail.utoronto.ca.
Croitoru D; Department of Medicine (Zipursky, Croitoru), University of Toronto; Department of Medicine (Zipursky), Sunnybrook Health Sciences Centre; Division of Clinical Pharmacology and Toxicology (Zipursky) and Institute of Health Policy, Management and Evaluation (Zipursky) and Division of Dermatology (Croitoru), University of Toronto, Toronto, Ont.

CMAJ ; 193(35): E1390, 2021 09 07.

Article in English | MEDLINE | ID: covidwho-1414241

Subject(s)

Angioedema/etiology; COVID-19/diagnosis; Urticaria/etiology; Adult; Angioedema/diagnosis; Angioedema/drug therapy; Anti-Allergic Agents/therapeutic use; COVID-19/complications; Humans; Male; Prednisone/therapeutic use; SARS-CoV-2/isolation & purification; Treatment Outcome; Urticaria/diagnosis; Urticaria/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / COVID-19 / Angioedema Type of study: Case report / Diagnostic study / Prognostic study Topics: Long Covid Limits: Adult / Humans / Male Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google